Mary G. Boyle

2.2k total citations · 1 hit paper
22 papers, 1.6k citations indexed

About

Mary G. Boyle is a scholar working on Infectious Diseases, Surgery and Epidemiology. According to data from OpenAlex, Mary G. Boyle has authored 22 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 10 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Mary G. Boyle's work include Antimicrobial Resistance in Staphylococcus (10 papers), Bladder and Urothelial Cancer Treatments (9 papers) and Clostridium difficile and Clostridium perfringens research (6 papers). Mary G. Boyle is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (10 papers), Bladder and Urothelial Cancer Treatments (9 papers) and Clostridium difficile and Clostridium perfringens research (6 papers). Mary G. Boyle collaborates with scholars based in United States. Mary G. Boyle's co-authors include Dean F. Bajorin, Harry W. Herr, John A. McCaffrey, Paul M. Dodd, Geralyn Higgins, Howard I. Scher, Madhu Mazumdar, Melissa Fazzari, Matthew I. Milowsky and Alexia Iasonos and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Mary G. Boyle

20 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy

1999 540 citations Dean F. Bajorin, Paul M. Dodd et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Mary G. Boyle

Since Specialization

Citations

This map shows the geographic impact of Mary G. Boyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary G. Boyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary G. Boyle more than expected).

Fields of papers citing papers by Mary G. Boyle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary G. Boyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary G. Boyle. The network helps show where Mary G. Boyle may publish in the future.

Co-authorship network of co-authors of Mary G. Boyle

This figure shows the co-authorship network connecting the top 25 collaborators of Mary G. Boyle. A scholar is included among the top collaborators of Mary G. Boyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary G. Boyle. Mary G. Boyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluating Personal and Environmental Decolonization Strategies for Children With Skin and Soft Tissue Infection and Their Households — A Randomized Clinical Trial 2025 ·Clinical Infectious Diseases ·Andrew Robinson, Mary G. Boyle, Patrick G. Hogan, Sara Malone, Melissa J. Krauss, Lisa Richardson, (unknown), (unknown), (unknown), Lauren Walsh, Ryley M. Thompson, (unknown), (unknown), Carey‐Ann D. Burnham, Stephanie A. Fritz	0
2	Invasive Community-Onset Gram-Positive Infections From July 2018 Through December 2022 at 2 Children's Hospitals 2023 ·Open Forum Infectious Diseases ·(unknown), (unknown), J. Chase McNeil, Kristina G. Hultén, (unknown), Mary G. Boyle, James J. Dunn, Stephanie A. Fritz, Sheldon L. Kaplan	6
3	Longitudinal Dynamics of Skin Bacterial Communities in the Context of Staphylococcus aureus Decolonization 2022 ·Microbiology Spectrum ·Stephanie A. Fritz, Todd Wylie, Haley Gula, Patrick G. Hogan, Mary G. Boyle, (unknown), (unknown), Carey‐Ann D. Burnham, Kristine M. Wylie	4
4	Factors associated with progression to infection in methicillin-resistant Staphylococcus aureus-colonized, critically ill neonates 2021 ·Journal of Perinatology ·(unknown), Patrick G. Hogan, (unknown), (unknown), (unknown), Mary G. Boyle, Ryley M. Thompson, Barbara Warner, Stephanie A. Fritz	14
5	Environmental Methicillin-resistant Staphylococcus aureus Contamination, Persistent Colonization, and Subsequent Skin and Soft Tissue Infection 2020 ·JAMA Pediatrics ·Patrick G. Hogan, (unknown), Ryley M. Thompson, (unknown), Mary G. Boyle, (unknown), John Morelli, (unknown), (unknown), David A. Hunstad, Juliane Bubeck Wardenburg, Sarah Gehlert, Carey‐Ann D. Burnham, Andrey Rzhetsky, Stephanie A. Fritz	27
6	HOME2 Study: Household Versus Personalized Decolonization in Households of Children With Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infection—A Randomized Clinical Trial 2020 ·Clinical Infectious Diseases ·Patrick G. Hogan, (unknown), (unknown), Mary G. Boyle, (unknown), Ryley M. Thompson, John Morelli, (unknown), David A. Hunstad, Juliane Bubeck Wardenburg, Andrey Rzhetsky, Sarah Gehlert, Carey‐Ann D. Burnham, Stephanie A. Fritz	18
7	Longitudinal, strain-specific Staphylococcus aureus introduction and transmission events in households of children with community-associated meticillin-resistant S aureus skin and soft tissue infection: a prospective cohort study 2019 ·The Lancet Infectious Diseases ·(unknown), Patrick G. Hogan, (unknown), Mary G. Boyle, Ryley M. Thompson, (unknown), John Morelli, (unknown), Rachel C. Orscheln, Juliane Bubeck Wardenburg, Sarah Gehlert, Carey‐Ann D. Burnham, Andrey Rzhetsky, Stephanie A. Fritz	64
8	852. The Cefazolin Inoculum Effect and Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children: Does It Matter? 2019 ·Open Forum Infectious Diseases ·(unknown), (unknown), Mary G. Boyle, Patrick G. Hogan, Jesús G. Vallejo, Kristina G. Hultén, Sheldon L. Kaplan, Stephanie A. Fritz	2
9	Interplay of personal, pet, and environmental colonization in households affected by community-associated methicillin-resistant Staphylococcus aureus 2018 ·Journal of Infection ·Patrick G. Hogan, (unknown), Mary G. Boyle, (unknown), John Morelli, Ryley M. Thompson, (unknown), Sarah Gehlert, (unknown), (unknown), Juliane Bubeck Wardenburg, Andrey Rzhetsky, Carey‐Ann D. Burnham, Stephanie A. Fritz	28
10	Comprehensive modeling reveals proximity, seasonality, and hygiene practices as key determinants of MRSA colonization in exposed households 2018 ·Pediatric Research ·(unknown), Patrick G. Hogan, (unknown), Mary G. Boyle, Ryley M. Thompson, John Morelli, (unknown), Sarah Gehlert, David Gaddis Ross, (unknown), Juliane Bubeck Wardenburg, Andrey Rzhetsky, Carey‐Ann D. Burnham, Stephanie A. Fritz	20
11	A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses 2017 ·New England Journal of Medicine ·Robert S. Daum, Loren G. Miller, Lilly Cheng Immergluck, Stephanie A. Fritz, C. Buddy Creech, David M. Young, Neha Kumar, (unknown), (unknown), Rebecca Hoagland, Samantha J. Eells, Mary G. Boyle, (unknown), Henry F. Chambers	127
12	Phase II Study of Sunitinib in Patients With Metastatic Urothelial Cancer 2010 ·Journal of Clinical Oncology ·David Gallagher, Matthew I. Milowsky, Scott R. Gerst, Nicole Ishill, Jamie C. Riches, Ashley Marie Regazzi, Mary G. Boyle, A. Trout, (unknown), Dean F. Bajorin	145
13	Sequential adjuvant chemotherapy after surgical resection of high‐risk urothelial carcinoma 2009 ·Cancer ·David Gallagher, Matthew I. Milowsky, Alexia Iasonos, Fernando Cotait Maluf, Paul Russo, Guido Dalbagni, S. Machele Donat, Mary G. Boyle, Junting Zheng, Jamie C. Riches, Dean F. Bajorin	9
14	A role for neoadjuvant gemcitabine plus cisplatin in muscle‐invasive urothelial carcinoma of the bladder 2008 ·Cancer ·Atreya Dash, Joseph A. Pettus, Harry W. Herr, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Paul Russo, Mary G. Boyle, Matthew I. Milowsky, Dean F. Bajorin	174
15	Prospective Trial of Ifosfamide, Paclitaxel, and Cisplatin in Patients with Advanced Non-transitional Cell Carcinoma of the Urothelial Tract 2007 ·Urology ·Matthew D. Galsky, Alexia Iasonos, Svetlana Mironov, Joseph Scattergood, S. Machele Donat, Bernard H. Bochner, Harry W. Herr, Paul Russo, Mary G. Boyle, Dean F. Bajorin	65
16	Phase II trial of dose‐dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function 2007 ·Cancer ·Matthew D. Galsky, Alexia Iasonos, Svetlana Mironov, Joseph Scattergood, Mary G. Boyle, Dean F. Bajorin	40
17	Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma 2006 ·Investigational New Drugs ·Matthew D. Galsky, Svetlana Mironov, Alexia Iasonos, Joseph Scattergood, Mary G. Boyle, Dean F. Bajorin	95
18	Phase I Evaluation of Sequential Doxorubicin Gemcitabine Then Ifosfamide Paclitaxel Cisplatin for Patients With Unresectable or Metastatic Transitional-Cell Carcinoma of the Urothelial Tract 2000 ·Journal of Clinical Oncology ·Paul M. Dodd, John A. McCaffrey, Susan Hilton, Madhu Mazumdar, Harry W. Herr, William K. Kelly, (unknown), Mary G. Boyle, Dean F. Bajorin	53
19	Outcome of Postchemotherapy Surgery After Treatment With Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Patients With Unresectable or Metastatic Transitional Cell Carcinoma 1999 ·Journal of Clinical Oncology ·Paul M. Dodd, John A. McCaffrey, Harry W. Herr, Madhu Mazumdar, Jennifer Bacik, Geralyn Higgins, Mary G. Boyle, Howard I. Scher, Dean F. Bajorin	118
20	Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy breakdown → 1999 ·Journal of Clinical Oncology ·Dean F. Bajorin, Paul M. Dodd, Madhu Mazumdar, Melissa Fazzari, John A. McCaffrey, Howard I. Scher, Harry W. Herr, Geralyn Higgins, Mary G. Boyle	540

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact